Silvia Manzanero

Silvia Manzanero

Auto-generated profile, based on publicly available information

Silvia Manzanero

Jamieson Trauma Institute (JTI), Metro North Health, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2010 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
HSHanne Schoenen
Hanne Schoenen
BBBarbara Bodendorfer
Barbara Bodendorfer
KHKelly Hitchens
Kelly Hitchens
SMSilvia Manzanero
Silvia Manzanero
KWKerstin Werninghaus
Kerstin Werninghaus
RLRoland Lang
Roland Lang
The mycobacterial cord factor trehalose-6,6-dimycolate (TDM) and its synthetic analog trehalose-6,6-dibehenate (TDB) are potent adjuvants for Th1/Th17 vaccination that activate Syk-Card9 signaling in APCs. In this study, we have further investigated the molecular mechanism of innate immune activation by TDM and TDB. The Syk-coupling adapter protein FcRγ was essential for macrophage activation and Th17 adjuvanticity. The FcRγ-associated C-type lectin receptor Mincle was expressed in macrophages and upregulated by TDM and TDB. Recombinant Mincle-Fc fusion protein specifically bound to the glycolipids. Genetic ablation of Mincle abolished TDM/TDB-induced macrophage activation and induction of T cell immune responses to a tuberculosis subunit vaccine. Macrophages lacking Mincle or FcRγ were impaired in the inflammatory response to Mycobacterium bovis bacillus Calmette-Guérin. These results establish that Mincle is a key receptor for the mycobacterial cord factor and controls the Th1/Th17 adjuvanticity of TDM and TDB.

1 June 2008 in The Journal of Immunology
Verified
Journal Article
Closed access
CWChristine A Wells
Christine A Wells
JSJudith A Salvage-Jones
Judith A Salvage-Jones
XLXin Li
Xin Li
KHKelly Hitchens
Kelly Hitchens
SBSuzanne Butcher
Suzanne Butcher
HDHume DA
Hume DA
The recognition of carbohydrate moieties by cells of the innate immune system is emerging as an essential element in antifungal immunity, but despite the number and diversity of lectins expressed by innate immune cells, few carbohydrate receptors have been characterized. Mincle, a C-type lectin, is expressed predominantly on macrophages, and is here shown to play a role in macrophage responses to the yeast Candida albicans. After exposure to the yeast in vitro, Mincle localized to the phagocytic cup, but it was not essential for phagocytosis. In the absence of Mincle, production of TNF-α by macrophages was reduced, both in vivo and in vitro. In addition, mice lacking Mincle showed a significantly increased susceptibility to systemic candidiasis. Thus, Mincle plays a novel and nonredundant role in the induction of inflammatory signaling in response to C. albicans infection.

5 September 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
DFD Yang-Wei Fann
D Yang-Wei Fann
SLS-Y Lee
S-Y Lee
SMS Manzanero
S Manzanero
STS-C Tang
S-C Tang
MGM Gelderblom
M Gelderblom
TAT V Arumugam
T V Arumugam
Multi-protein complexes called inflammasomes have recently been identified and shown to contribute to cell death in tissue injury. Intravenous immunoglobulin (IVIg) is an FDA-approved therapeutic modality used for various inflammatory diseases. The objective of this study is to investigate dynamic responses of the NLRP1 and NLRP3 inflammasomes in stroke and to determine whether the NLRP1 and NLRP3 inflammasomes can be targeted with IVIg for therapeutic intervention. Primary cortical neurons were subjected to glucose deprivation (GD), oxygen–glucose deprivation (OGD) or simulated ischemia-reperfusion (I/R). Ischemic stroke was induced in C57BL/6J mice by middle cerebral artery occlusion, followed by reperfusion. Neurological assessment was performed, brain tissue damage was quantified, and NLRP1 and NLRP3 inflammasome protein levels were evaluated. NLRP1 and NLRP3 inflammasome components were also analyzed in postmortem brain tissue samples from stroke patients. Ischemia-like conditions increased the levels of NLRP1 and NLRP3 inflammasome proteins, and IL-1β and IL-18, in primary cortical neurons. Similarly, levels of NLRP1 and NLRP3 inflammasome proteins, IL-1β and IL-18 were elevated in ipsilateral brain tissues of cerebral I/R mice and stroke patients. Caspase-1 inhibitor treatment protected cultured cortical neurons and brain cells in vivo in experimental stroke models. IVIg treatment protected neurons in experimental stroke models by a mechanism involving suppression of NLRP1 and NLRP3 inflammasome activity. Our findings provide evidence that the NLRP1 and NLRP3 inflammasomes have a major role in neuronal cell death and behavioral deficits in stroke. We also identified NLRP1 and NLRP3 inflammasome inhibition as a novel mechanism by which IVIg can protect brain cells against ischemic damage, suggesting a potential clinical benefit of therapeutic interventions that target inflammasome assembly and activity.

1 September 2013 in Ageing Research Reviews
Verified
Journal Article
Closed access
DFDavid Yang-Wei Fann
David Yang-Wei Fann
SLSeung-Yoon Lee
Seung-Yoon Lee
SMSilvia Manzanero
Silvia Manzanero
PCPrasad Chunduri
Prasad Chunduri
CSChristopher G. Sobey
Christopher G. Sobey
TAThiruma V. Arumugam
Thiruma V. Arumugam

1 April 2013 in Neurochemistry International
Verified
Journal Article
Closed access
SMSilvia Manzanero
Silvia Manzanero
TSTomislav Santro
Tomislav Santro
TAThiruma V. Arumugam
Thiruma V. Arumugam